BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hutchison D, Peabody H, Kuperus JM, Humphrey JE, Ryan M, Moriarity A, Brede CM, Lane BR. Management of prostate cancer after holmium laser enucleation of the prostate. Urol Oncol 2021;39:297.e1-8. [PMID: 33221258 DOI: 10.1016/j.urolonc.2020.11.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Capitanio U, Autorino R, Bandini M, Briganti A, Cheng L, Cooperberg MR, Dehò F, Gallina A, Klotz L, Lane B, Montironi R, Salonia A, Stief C, Tombal B, Montorsi F. Incidental Prostate Cancer (cT1a-cT1b) Is a Relevant Clinical and Research Entity and Should Be Fully Discussed in the International Prostate Cancer Guidelines. Eur Urol Oncol 2021:S2588-9311(21)00049-3. [PMID: 33814342 DOI: 10.1016/j.euo.2021.03.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Mauler DJ, Sella DM, Dora CD. Utilizing Preoperative Magnetic Resonance Imaging to Self-assess Enucleation Ratio in Holmium Laser Enucleation of the Prostate. Urology 2021:S0090-4295(21)01067-0. [PMID: 34813831 DOI: 10.1016/j.urology.2021.11.009] [Reference Citation Analysis]